首页 | 本学科首页   官方微博 | 高级检索  
     

硼替唑米治疗多发性骨髓瘤异基因移植后慢性移植物抗宿主病:一举两得
引用本文:李增军,邹德慧,邱录贵. 硼替唑米治疗多发性骨髓瘤异基因移植后慢性移植物抗宿主病:一举两得[J]. 临床血液学杂志, 2011, 0(4): 394-396
作者姓名:李增军  邹德慧  邱录贵
作者单位:中国医学科学院北京协和医学院血液学研究所血液病医院;
基金项目:国家科技支撑计划项目(No:2008BAI61B01); 天津市科技支撑计划项目(No:09ZCGYSF01000)
摘    要:目的:探讨硼替佐米治疗多发性骨髓瘤异基因移植后移植物抗宿主病(GVHD)及原发病的双重作用.方法:报道1例异基因移植后发生慢性难治性GVHD、同时可疑复发的多发性骨髓瘤患者应用硼替佐米后的效果;同时对硼替佐米治疗GVHD的文献进行复习.结果:应用硼替佐米后患者慢性GVHD获得部分治疗反应,同时巩固了原发病的疗效.文献报...

关 键 词:多发性骨髓瘤  硼替唑米  异基因移植  移植物抗宿主病

Bortezomib therapy for cGVHD after allo-stem cell transplantation for multiple myeloma patient:kill two birds with one stone
LI Zengjun ZOU Dehui QIU Lugui. Bortezomib therapy for cGVHD after allo-stem cell transplantation for multiple myeloma patient:kill two birds with one stone[J]. Journal of Clinical Hematology, 2011, 0(4): 394-396
Authors:LI Zengjun ZOU Dehui QIU Lugui
Affiliation:LI Zengjun ZOU Dehui QIU Lugui(Institute of Hematology and Blood Diseases Hospital,CAMS & PUMC,Tianjin,300020,China)
Abstract:Objective:To explore the dual function of bortezomib on multiple myeloma(MM) itself and on graft versus host disease(GVHD) after allo-stem cell transplantation.Method:A case of MM patient,who suffered from refractory chronic graft versus host disease(cGVHD) after allo-stem cell transplantation and unconfirmed recurrence of MM,was treated with bortezomib.The documents about the role of bortezomib on GVHD were reviewed briefly.Result:Partial response was achieved on cGVHD and the primary disease was consolida...
Keywords:multiple myeloma  bortezomib  allo-stem cell transplantation  graft versus host disease  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号